Related Experiment Videos
Streptococcal myositis. A report of two cases
H E Demey1, G C Goovaerts, S R Pattyn
1Universitair Ziekenhuis Antwerpen-UIA, Wilrijk, Belgium.
Acta Clinica Belgica
|January 1, 1991
Summary
Acute streptococcal myositis is a severe condition. Clindamycin is suggested as the preferred antibiotic, while nonsteroidal anti-inflammatory drugs may contribute to its development.
Area of Science:
- Infectious Diseases
- Rheumatology
- Critical Care Medicine
Background:
- Acute streptococcal myositis is a rare but severe bacterial infection affecting muscle tissue.
- Understanding the pathogenesis and optimal treatment is crucial for patient outcomes.
Observation:
- Two cases of acute streptococcal myositis are presented, highlighting the severity and complications.
- One patient experienced fatal multiple organ failure, while the other survived significant complications.
Findings:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) were administered to both patients and may play a role in disease development.
- Mouse models suggest clindamycin as the antibiotic of choice for treating streptococcal myositis.
Implications:
- This study underscores the aggressive nature of streptococcal myositis and the potential risks associated with NSAID use.
- Clindamycin emerges as a potential front-line antibiotic, warranting further clinical investigation for this serious infection.